Eli Lilly and Company (NYSE: LLY) is expected to release earnings results for its fourth quarter, before the opening bell on Feb. 6, 2024.
Analysts expect the company to report quarterly earnings at $2.19 per share, up from year-ago earnings of $2.09 per share. The company is projected to report revenue of $8.93 billion, compared to $7.3 billion in the year-earlier quarter, according to data from Benzinga Pro.
The firm is reportedly engaged in discussions with the German government to lift the ban on the public health system covering the costs of weight-loss treatments.
Eli Lilly shares rose 5.8% to close at $706.20 on Monday.
Benzinga readers can access the latest analyst ratings on …